BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
Individual Coverage Health Reimbursement Arrangements (ICHRAs) are continuing to gain the interest of employers and investors. And Venteur’s $20 million Series A round announced on Tuesday is another example of that.
San Francisco-based Venteur helps…
Continue Reading
Not all AI in healthcare carries the same risk. Some applications can be deployed quickly with minimal oversight, while others—like clinical decision support—demand rigorous validation. In this interview, Ben Scharfe, EVP of AI Initiatives…
Continue Reading
Background: Accessible mental health care, delivered via mobile apps or web-based services, may be essential for military members, public safety personnel (PSP), and veterans, as they report numerous barriers to seeking in-person care and…
Continue Reading
Rapid growth in genetic testing usage resulted in declining availability of genetic counselors (GCs) per ordered tests, prolonging the waiting times for face-to-face (F2F) counseling. We evaluated the digital genetic assistant (DGA) for reproductive…
Continue Reading
Loren Larsen, CEO and Co-Founder, Videra Health
The mental health landscape is experiencing a surge in demand for services. With limited resources and an ever-growing client base, mental health providers face a daunting challenge: ensuring high-quality care for each individual while managing…
Continue Reading
The Information Commissioner’s Office (ICO) has reduced the fine imposed on Advanced to £3.07 million for security failings that put the personal information of almost 80,000 people at risk.
The fine, which is the first…
Many people are dealing with a medication mess. They get prescriptions from different specialties (neurology, cardiology, etc.), who are busy and can't always check for contraindications or adverse effects. The patient then picks up…
Continue Reading
Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million. Growth Equity at Goldman Sachs Alternatives led…
Continue Reading
Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million. Growth Equity at Goldman Sachs Alternatives led…
Continue Reading
